AU2002352089A1 - Medical use of antibodies directed against human matrix metalloproteinases or related tissue proteinases for the treatment of abnormal uterine bleeding and endometriosis - Google Patents

Medical use of antibodies directed against human matrix metalloproteinases or related tissue proteinases for the treatment of abnormal uterine bleeding and endometriosis

Info

Publication number
AU2002352089A1
AU2002352089A1 AU2002352089A AU2002352089A AU2002352089A1 AU 2002352089 A1 AU2002352089 A1 AU 2002352089A1 AU 2002352089 A AU2002352089 A AU 2002352089A AU 2002352089 A AU2002352089 A AU 2002352089A AU 2002352089 A1 AU2002352089 A1 AU 2002352089A1
Authority
AU
Australia
Prior art keywords
endometriosis
treatment
directed against
antibodies directed
medical use
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002352089A
Other versions
AU2002352089A8 (en
Inventor
Pierre Joseph Courtoy
Yves Joseph Eeckhout
Etienne Michel Marbaix
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universite Catholique de Louvain UCL
Original Assignee
Universite Catholique de Louvain UCL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universite Catholique de Louvain UCL filed Critical Universite Catholique de Louvain UCL
Publication of AU2002352089A1 publication Critical patent/AU2002352089A1/en
Publication of AU2002352089A8 publication Critical patent/AU2002352089A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2002352089A 2001-11-23 2002-11-21 Medical use of antibodies directed against human matrix metalloproteinases or related tissue proteinases for the treatment of abnormal uterine bleeding and endometriosis Abandoned AU2002352089A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP01870260 2001-11-23
EP01870260.5 2001-11-23
PCT/EP2002/013074 WO2003044058A2 (en) 2001-11-23 2002-11-21 Medical use of antibodies directed against human matrix metalloproteinases or related tissue proteinases for the treatment of abnormal uterine bleeding and endometriosis

Publications (2)

Publication Number Publication Date
AU2002352089A1 true AU2002352089A1 (en) 2003-06-10
AU2002352089A8 AU2002352089A8 (en) 2003-06-10

Family

ID=8185056

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002352089A Abandoned AU2002352089A1 (en) 2001-11-23 2002-11-21 Medical use of antibodies directed against human matrix metalloproteinases or related tissue proteinases for the treatment of abnormal uterine bleeding and endometriosis

Country Status (2)

Country Link
AU (1) AU2002352089A1 (en)
WO (1) WO2003044058A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2369498T3 (en) * 2003-04-04 2011-12-01 Yeda Research And Development Co., Ltd. ANTIBODIES TO INHIBIT THE ACTIVITY OF MMP-2 AND MMP-9.
WO2009111450A2 (en) * 2008-03-03 2009-09-11 Dyax Corp. Metalloproteinase 9 binding proteins
CN103140240B (en) 2010-08-27 2015-01-21 吉联亚生物科技有限公司 Antibodies to matrix metalloproteinase 9
WO2013059439A2 (en) 2011-10-21 2013-04-25 Dyax Corp. Combination therapy comprising an mmp-14 binding protein
US9732156B2 (en) 2012-02-29 2017-08-15 Gilead Biologics, Inc. Methods of treating rheumatoid arthritis using antibodies to matrix metalloproteinase 9

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9607120D0 (en) * 1996-04-04 1996-06-12 Chiroscience Ltd Compounds

Also Published As

Publication number Publication date
WO2003044058A3 (en) 2004-01-22
WO2003044058A2 (en) 2003-05-30
AU2002352089A8 (en) 2003-06-10

Similar Documents

Publication Publication Date Title
AU2002305400A1 (en) Medical device and methods of use for glaucoma treatment
EP1278466A4 (en) Miniaturized surgical forceps and methods of making the same
AU3886199A (en) Medical device for dissolution of tissue within the human body
AU2001231095A1 (en) System for organ and tissue preservation and hypothermic blood substitution
EP1620006A4 (en) Devices, systems and methods for bioimpendence measurement of cervical tissue and methods for diagnosis and treatment of human cervix
AU3109501A (en) System for organ and tissue preservation and hypothermic blood substitution
AU2002323258A1 (en) Diagnosis and treatment of vascular disease
AU2001280440A1 (en) Treatment of human herpesviruses using hyperthermia
AU2002367535A1 (en) Diagnosis and treatment of vascular disease
AU2002248319A1 (en) Pharmaceutical composition for the prevention and treatment of scar tissue
AU2002326813A1 (en) Diagnosis and treatment of vascular disease
PL366802A1 (en) Use of il-18 inhibitors for the treatment and/or prevention of heart disease
AU2001273475A1 (en) Coagulator and spinal disk surgery
AU2002352089A1 (en) Medical use of antibodies directed against human matrix metalloproteinases or related tissue proteinases for the treatment of abnormal uterine bleeding and endometriosis
AU2002341880A1 (en) Diagnosis and treatment of vascular disease
AU2002341604A1 (en) Diagnosis and treatment of vascular disease
AU2001242490A1 (en) Device for treating human and/or animal tissue
AU2002306600A1 (en) Sperm protein 17 for the diagnosis and treatment of cancer
EP1411964A4 (en) Peptides which modulate blood coagulation and methods of use thereof
AU2001296477A1 (en) Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas
AU5611701A (en) Agent for the diagnosis and therapy of viral diseases
AU2003242430A1 (en) Agent neutralizint tissue factor inhibitor and agent neutralizing activated blood coagulation factor viii preparation
AU2002340728A1 (en) Tt virus sequences in human tumoral tissue, agent for the detection thereof and tumoral therapy
AU2002319591A1 (en) Diagnosis and treatment of vascular disease
AU2002240745A1 (en) Diagnosis and treatment of blood disorders

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase